科兴生物疫苗有效率是50.38%

China's Sinovac vaccine has "general efficacy" of 50.4% in Brazil trials, says Butantan

January 12, 2021, 11:31 AM

RIO DE JANEIRO, Jan 12 (Reuters) - A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.38% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency.


On Thursday, Butantan officials had celebrated results showing 78% efficacy against mild COVID-19 cases, a rate they have since described as "clinical efficacy."


Ricardo Palacios, medical director for clinical research at the Butantan biomedical center in Sao Paulo, said the new figure included infections that were so mild or asymptomatic that they did not need clinical care. (Reporting by Gabriel Stargardter and Pedro Fonseca Editing by Brad Haynes)

所有跟帖： 

• 直觉这个数字不离谱。 瑞辉的95%数字"太完美“ -SwiperTheFox- ♂ (0 bytes) () 01/12/2021 postreply 13:21:15

• 别人用的是新技术嘛。如果有的选，我还是选老技术 -cn_abcd- ♂ (0 bytes) () 01/12/2021 postreply 13:23:06

• 怀疑目前中国多处出现破口和疫苗有关 -laworderus- ♂ (0 bytes) () 01/12/2021 postreply 13:26:46

• 是的，一天新增一百多是到处破口，一天２０W是中规中矩。 -118ibm- ♂ (0 bytes) () 01/12/2021 postreply 13:30:33

• 石家庄是教会聚会的结果 -云意- ♂ (0 bytes) () 01/12/2021 postreply 13:32:15

• 有没有脑疫苗，打了可以让人不再蠢笨的那种，，， -118ibm- ♂ (0 bytes) () 01/12/2021 postreply 13:33:44

• 也有说这数据不对 -yddad- ♂ (331 bytes) () 01/12/2021 postreply 17:38:53